Work

Supplementary Figures 1 & 2 from A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 1. Immunohistochemical expression of Ki-67 after degarelix, degarelix and bicalutamide, or LHRH agonist and bicalutamide. (ONLINE ONLY) Supplementary Figure 2. Immunohistochemical expression of alpha-methylacyl-CoA racemase (AMACR) after degarelix, degarelix and bicalutamide, or LHRH agonist and bicalutamide. (ONLINE ONLY)

DOI: 10.1158/1078-0432.22465850

Authors: Rashid K. Sayyid, Andrew Evans, Karen Hersey, Ranjena Maloni, Antonio Hurtado-Coll, Girish Kulkarni, Antonio Finelli, Alexandre R. Zlotta, Robert Hamilton, Martin Gleave, Neil E. Fleshner

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361886300

Cites:

Cited by:

Related to: 10